Elevated Cardiac Troponin I in Sepsis and Septic Shock: No Evidence for Thrombus Associated Myocardial Necrosis
Open Access
- 3 February 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2), e9017
- https://doi.org/10.1371/journal.pone.0009017
Abstract
Elevated cardiac troponin I (cTnI) is frequently observed in patients with severe sepsis and septic shock. However, the mechanisms underlying cTnI release in these patients are still unknown. To date no data regarding coagulation disturbances as a possible mechanism for cTnI release during sepsis are available. Consecutive patients with systemic inflammatory response syndrome (SIRS), sepsis or septic shock without evidence of an acute coronary syndrome were analyzed. Coagulation parameters (clotting time (CT), clot formation time (CFT), maximum clot firmness (MCF), α-angle) were assessed in native whole blood samples, and using specific activators to evaluate the extrinsic and intrinsic as well as the fibrin component of the coagulation pathway with the use of rotational thrombelastometry (ROTEM). Thirty-eight patients were included and 22 (58%) were cTnI-positive. Baseline characteristics between TnI-positive and -negative patients were similar. The CT, CFT, MCF and the α-angle were similar between the groups with trends towards shorter CT in the extrinsic and fibrin activation. We found no differences in coagulation parameters analyzed with rotational thrombelastometry between cTnI-positive and -negative patients with SIRS, severe sepsis, and septic shock. These findings suggest that pathophysiological mechanisms other than thrombus-associated myocardial damage might play a major role, including reversible myocardial membrane leakage and/or cytokine mediated apoptosis in these patients.Keywords
This publication has 29 references indexed in Scilit:
- Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis‐prone patientsScandinavian Journal of Clinical and Laboratory Investigation, 2006
- Thromboelastography Maximum Amplitude Predicts Postoperative Thrombotic Complications Including Myocardial InfarctionAnesthesia & Analgesia, 2005
- Platelet–monocyte aggregates predict troponin rise after percutaneous coronary intervention and are inhibited by AbciximabInternational Journal of Cardiology, 2005
- Platelet and Leukocyte Activation Correlate with the Severity of Septic Organ DysfunctionShock, 2002
- Increased troponin in patients with sepsis and septic shock: myocardial necrosis or reversible myocardial depression?Intensive Care Medicine, 2001
- Thromboelastography for Monitoring Prolonged Hypercoagulability After Major Abdominal SurgeryAnesthesia & Analgesia, 2001
- Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum.The Journal of Experimental Medicine, 1996
- A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter studyJama-Journal Of The American Medical Association, 1993
- Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins.The Journal of Experimental Medicine, 1989
- A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance.JCI Insight, 1985